Back Meet the five projects selected for our 2022 Venture Builder Program

Meet the five projects selected for our 2022 Venture Builder Program



Xartec Salut has shared the results of the 2022 Venture Builder Program in order to support and accelerate the technology transfer of health technologies through Spin-offs born within the network. A catalyst to boost the creation of new companies in the HealhtTech ecosystem, enhacing their long-term survival and maximizing their impact in the market while providing specific resources and support.

The beneficiaries of this cut-off have been VIRTEST, a pre-procedural planning for Left Atrial Appendage Occlusion (LAAO) by PhySense-UPF; MIL@b, implementing an e-infrastructure based on Cloud and Edge Computing for data analysis in metabolomics, by Universitat Rovira i Virgili (URV); Ephion Health, the platform to develop and deploy clinical measures for patient mobility by Eurecat; Share4Rare, a collective online platform with the ambition to make a difference for rare disease patients and their families by Institut de Recerca Sant Joan de Déu (IRSJD) and Centre de Recerca en Enginyeria Biomèdica (CREB) and ICOnnecta’t with a digital health system aiming to reduce the impact of cancer, increase well-being and quality of life during follow-up and continued patient care, by Institut Català d’Oncologia (ICO) – Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). 

The call is launched by Xartec Salut annually to select the most promising HealthTech projects to be accompanied in their way to becoming Spin-offs with a budget for this edition of 130.000€. The program will cover some key factors of new venture success, such as: legal support, mentoring, business model definition, training, coaching and capacity building for the leader, investment and so on.

This project is co-funded by the European Union through the European Regional Development Fund (FEDER, Fondo Europeo de Desarrollo Regional).


Taken from:



SDG - Sustainable Development Goals:

Els ODS a la UPF